Infection Control Market by Product (Sterilization (Dry Heat, Radiation, Hydrogen Peroxide, EtO), Disinfection (Wipes, Spray, Disinfectors), Protective Barriers, Endoscopic Reprocessing), End User (Medical Device, Hospitals) - Global Forecast to 2030

Updated on : April 24, 2023

The global infection control market in terms of revenue was estimated to be worth $50.0 billion in 2023 and is poised to reach $58.3 billion by 2030, growing at a CAGR of 3.1% from 2023 to 2030.

The new research study consists of an analysis of market industry trends. The new research study includes industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behavior in the market. The increasing outsourcing of sterilization services between pharmaceutical companies, hospitals and medical device manufacturers, the increasing number of surgical procedures, the growth of the geriatric population and the subsequent increase in the incidence of chronic diseases are the factors that contribute to the growth of the market.

Infection Control Market Dynamics

Driver: High Incidence of Hospital-Acquired Infections (HAIs)

Hospital-acquired infections (HAIs) are nosocomial infections that emerge during a patient's stay in a hospital or associated facility and are not detected during admission. They are a major source of illness and mortality all across the world. Hospital-acquired pneumonia infections, central line-associated bloodstream infections, surgical-site infections, catheter-associated urinary tract infections, Clostridium difficile infections, and ventilator-associated pneumonia are the most common types of infections. The use of contaminated medical equipment during diagnostic and therapeutic operations is one of the leading sources of HAIs.

Restraint: The harmful effects of chemical disinfectants

Toxic characteristics exist in commercially marketed chemical disinfectants. Sodium hypochlorite, for example, is excellent against bloodborne infections but is highly corrosive and a respiratory irritant, making it harmful when discharged into the environment and hazardous to cleaning employees. When applied incorrectly, these disinfectants might pose environmental risks. In the United States, disinfectants must be registered with the Environmental Protection Agency (EPA), which considers these solutions as pesticides. The Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) governs their use. There is presently no green certificate available for disinfectants on the market.

Opportunity: The expanding healthcare business and the outsourcing of operations to developing countries

Emerging economies such as India, Brazil, China, and South Africa provide significant opportunities for players in the sterilization and disinfection markets. The need to improve healthcare services in these economies is driven primarily by rapidly aging populations, high patient numbers, growth in per capita income, and growing awareness. Additionally, more than half of the world's population resides in India and China, and these markets are home to a large patient base. Improvements in healthcare infrastructure, such as the creation of new facilities, have been a key trend in emerging markets, alongside growing awareness of sterilization of medical products.

Challenge: Development of alternative technologies for surface disinfection

Many innovative technologies are being researched and evaluated as alternatives to the conventional manual techniques of surface disinfection. These are some examples:

  • Electrolyzed water (hypochlorous acid)
  • Plasma at low atmospheric pressure
  • Self-cleaning surfaces
  • No-touch decontamination technologies such as aerosol, vaporised hydrogen peroxide, and pulsed xenon UV light systems

These technologies are at various phases of research and testing and are yielding promising outcomes. For example, reactive oxygen species created by cold air atmospheric systems have been demonstrated in laboratory tests to exhibit bactericidal action against a number of diseases, with varying effectiveness against C. difficile spores. Following commercialisation, these technologies will provide a significant threat to the expansion of existing techniques of surface disinfection, such as the use of liquids and sprays, in the future years.

The sector of protective barriers accounted for the majority of the infection control market.

The market is divided into sterilisation goods and services, cleaning and disinfection products, protective barriers, endoscope reprocessing products, and other infection control products based on product and service. The sector of protective barriers accounted for the majority of the imarket. This can be ascribed to the increasing use of them in all surgical procedures, more knowledge about infection management, and a greater emphasis on preventing HAIs.

During the forecast period, the sterilisation equipment sector is predicted to have the greatest CAGR in the infection control market.

The sterilisation goods and services market is divided into three categories: sterilisation equipment, contract sterilisation services, and consumables and accessories. During the projection period, the sterilisation equipment segment is predicted to increase the most. This is due to its low cost, simplicity of setup, and wide range of applications.

During the projection period, the medical nonwovens segment held the greatest share of the infection control market.

The market is divided into four categories based on protective barriers: medical nonwovens, gloves, covers & closures, and eyewear. The protective barrier market was dominated by the medical nonwovens category. The expanding number of surgical procedures, growing preference for single-use goods, increased awareness of health concerns, and high disposable incomes all contribute to the medical nonwovens segment's big share.

The hospitals and clinics sector is expected to grow the most in the infection control market during the projected period.

On the basis of end user, the market is segmented into life science industry, hospitals & clinics, medical device companies, pharmaceutical companies, food industry and other end users (veterinary industry, cosmetics industry, dietary supplement manufacturers and other health care). service providers such as long-term care facilities and diagnostic and imaging centers). Hospitals and clinics segment is expected to register the highest growth during the forecast period. This can be attributed to the increasing prevalence of HAIs, the increasing number of hospitals and clinics in Asian countries, and the increasing volume of surgeries performed.

North America has the biggest market share for infection control

North America has the biggest market share. The region's large share can be attributed to an increase in the geriatric population in the coming years, which will result in an increase in the prevalence of chronic diseases, the implementation of favourable government initiatives and strict regulations in sterilisation and disinfection, the presence of advanced health infrastructures in the United States and Canada, and the acceptance of new surface disinfectant compositions (based on hydrogen peroxide and peracetic acid).

The prominent players in the infection control market are Steris Plc (US), Getinge AB (Sweden), Ecolab, Inc. (US),3M Company (US), Advanced Sterilization Products (US), Sotera Health Company (US), MMM Group (Germany), Matachana Group (Spain), Belimed AG (Switzerland), Metrex Research LLC (US), Reckitt Benckiser (UK), Pal International (UK), MelagMedizintechnik GmbH & Co. KG (Germany), The Miele Group (Germany), Systec GmbH (Germany), Contec,Inc.(US), and Continental Equipment Company (US).

Infection Control Market Report Scope

The study categorizes the infection control market to forecast revenue and analyze trends in each of the following submarkets:

By Product & Service

  • Sterilization Products and Services
    • Sterilization Equipment
      • Heat Sterilization Equipment
        • Moist Heat Sterilizers
        • Dry Heat Sterilizers
      • Low-Temperature Sterilization
        • Hydrogen Peroxide Sterilization
        • Ethylene Oxide Sterilization (ETO)
        • Formaldehyde Sterilization
        • Other Low-Temperature Sterilization
      • Radiation Sterilization
      • Filtration Sterilization
      • Other Equipment
    • Contract Sterilization Services Market
      • ETO Sterilization Services
      • Gamma Sterilization Services
      • E-Beam Sterilization Services
      • Steam Sterilization Services
      • Other Sterilization Services
    • Consumables and Accessories
      • Sterilization Indicators
        • Chemical Indicators
        • Biological Indicators
      • Packaging Accessories
  • Cleaning and Disinfection Products
    • Disinfectants
      • Disinfectants, By Product Type
        • Hand Disinfectants
        • Surface Disinfectants
        • Skin Disinfectants
        • Instrument Disinfectants
      • Disinfectants, By Formulation
        • Disinfectant Wipes
        • Liquid Disinfectants
        • Disinfectant Sprays
      • Disinfectants, By EPA Classification
        • Low-Level Disinfectants
        • Intermediate-Level Disinfectants
        • High-Level Disinfectants
    • Cleaning and Disinfection Equipment
      • Washer Disinfectors
      • Flusher Disinfectors
      • UV-Ray Disinfectors
      • Ultrasonic Cleaners
      • Other Cleaning and Disinfection Equipment
    • Lubricants and Cleaning Solutions
    • Disinfection and Cleaning Accessories
  • Protective Barriers
    • Medical Nonwovens
      • Surgical Drapes
      • Surgical Gowns
      • Face Masks
    • Covers and Closures
    • Goggles
    • Gloves
  • Endoscope Reprocessing Products
    • Endoscope Reprocessing Consumables
    • Endoscope Reprocessing Equipment
      • Automated Endoscope Reprocessors
      • Endoscope Tracking Systems
    • Other Endoscope Reprocessing Products
  • Other Infection Control Products

By End User

  • Hospitals & Clinics
  • Medical Device Companies
  • Pharmaceutical Companies
  • Life Science Industry
  • Food Industry
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Switzerland
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Southeast Asia
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Recent Developments

  • In 2022, STERIS opened a new medical device testing facility in Leipzig, Germany. This new facility will be used for medical device manufacturing. It has additional packaging and microbiological testing capabilities and complements the existing E-beam, gamma, and testing services offered in Germany.
  • In 2021, STERIS acquired Cantel, a global provider of infection prevention products and services, through a US subsidiary, to diversify its vast portfolio of sterilization services.
  • In 2021, Getinge entered into a strategic partnership with researchers from the School of Business, Economics and Law at the University of Gothenburg, Sweden, to undertake customer-centric innovation and sustainability activities.
  • In 2021, Nelson Labs and Sterigenics Germany opened a facility for microbiological laboratory testing in Wiesbaden, Germany. This will address the significantly increased demand for these services by the medical device and pharmaceutical industries.

In 2020, Sotera Health Company acquired Iotron, a key outsourced provider of E-beam sterilization services in North America. This acquisition helped expand its electron beam (E-beam) footprint and added new expertise to its Sterigenics business.

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!


One of our marquee services We profile relevant start-up companies in the market.


Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.